Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408167![]() ((R)-2-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)e...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408262![]() ((S)-6-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408173![]() (US10336775, Example 77 | US10336775, Example 78) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408195![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408202![]() (N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408218![]() (N-(2-(4-(1-(benzo[c][1,2,5]thiadiazol-5-yl)ethyl)p...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408230![]() ((S) 2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408247![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408263![]() ((S)-6-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408265![]() (3-(2-(4-((S)-1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408269![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408152![]() ((R)-2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408168![]() (N-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408193![]() (N-(5-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)et...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408203![]() (N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408205![]() (2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408210![]() (N-(5-(4-(1-(benzo[d]thiazol-5-yl)ethyl)piperazin-1...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408273![]() ((S)-1-(2-(4-((S)-1-(benzo[d][1,3]dioxol-5-yl)ethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408133![]() (5-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408201![]() (N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408219![]() (N-(5-(4-(1-(benzo[c][1,2,5]thiadiazol-5-yl)ethyl)p...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408244![]() (1-(2-(4-((S)-1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408266![]() ((S)-2-(6-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408140![]() (N-(5-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408204![]() (N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408253![]() ((S)-N-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408271![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408273![]() ((S)-1-(2-(4-((S)-1-(benzo[d][1,3]dioxol-5-yl)ethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408144![]() (2-(4-(1-(Benzo[d](1,3)dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408189![]() (N-(2-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-yl)p...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408194![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408224![]() (N-(5-(4-(1-(2,3-dihydrobenzofuran-6-yl)ethyl)piper...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408228![]() ((S)-5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408229![]() ((S)-N-(5-(4-(1-(benzo[d]thiazol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408246![]() (N-(5-(4-(1-(2-methylbenzo[d]thiazol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408251![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408260![]() ((S)-1-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408261![]() ((S)-(6-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piper...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408270![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408148![]() ((2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408161![]() ((R)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408185![]() ((R)-N-(5-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408212![]() (N-(2-(4-(1-(benzo[d]thiazol-5-yl)ethyl)piperazin-1...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408225![]() (N-(2-(4-(1-(2,3-dihydrobenzofuran-6-yl)ethyl)piper...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408243![]() ((S)-1-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408249![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408252![]() ((S)-2-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408268![]() ((S)-1-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)-4-(5-(me...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408159![]() ((R)-2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)e...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408164![]() ((R)-N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408182![]() (N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408233![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408256![]() ((S)-1-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408258![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408264![]() ((S)-4-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408130![]() ((R)-2-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)e...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408153![]() ((R)-2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)e...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408176![]() (N-((2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408177![]() ((R)-(2-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408181![]() (N-((2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408192![]() (N-(2-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)et...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408245![]() (N-(2-(4-(1-(2-methylbenzo[d]thiazol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408257![]() ((S)-1-(2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408170![]() ((R)-(2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | <50 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408135![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408150![]() (N-(4-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408154![]() (6-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408158![]() ((S)-2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)e...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408188![]() (N-methyl-2-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408207![]() (5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408208![]() (5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408209![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408248![]() (6-(1-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)eth...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408107![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408121![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408137![]() (5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408142![]() (4-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408155![]() ((R)-2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408178![]() (N-(5-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-yl)-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408206![]() (N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408216![]() (N-(2-(4-(1-(quinolin-7-yl)ethyl)piperazin-1-yl)pyr...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408275![]() (1-(4-Bromo-3-methoxyphenyl)-4-(1-(2,3-dihydrobenzo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408104![]() (-5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408125![]() ((2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408134![]() (5-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408136![]() (4-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408191![]() ((S)-7-(1-(4-(pyrimidin-2-yl)piperazin-1-yl)ethyl)q...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408126![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408127![]() (3-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408163![]() ((2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408200![]() ((S)-6-(1-(4-(5-(trifluoromethyl)pyrimidin-2-yl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408237![]() ((S)-5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408259![]() (Ethyl (S)-6-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408267![]() ((S)-1-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)-4-(5-bro...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408276![]() (1-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethyl)-4...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408114![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408147![]() (Ethyl 2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipe...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408175![]() (4-((2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408199![]() (6-(1-(4-(5-ethylpyrimidin-2-yl)piperazin-1-yl)ethy...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408211![]() (N-(5-(4-(1-(quinolin-7-yl)ethyl)piperazin-1-yl)-1,...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408242![]() ((S)-1-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)-4-(5-(tr...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408119![]() (N-(2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408120![]() (4-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408132![]() (5-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408143![]() (2-(4-(1-(Benzo[d](1,3)dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408146![]() (2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)ethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408151![]() (1-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)-4-(5-nitropy...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408179![]() (6-(1-(4-(pyrimidin-2-yl)piperazin-1-yl)ethyl)quino...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408215![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408238![]() ((S)-5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408240![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408272![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408118![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408124![]() ((2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408131![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408139![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408169![]() ((2-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethy...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408180![]() ((2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408235![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408111![]() ((R)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408122![]() ((R)-2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408157![]() ((R)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408187![]() (7-(1-(4-(pyrimidin-2-yl)piperazin-1-yl)ethyl)quino...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408198![]() (6-(1-(4-(5-Methylpyrimidin-2-yl)piperazin-1-yl)eth...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 125 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408226![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408031![]() (2-(1-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperidin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408149![]() (2-(4-(1-(2,3-dihydrobenzofuran-5-yl)ethyl)piperazi...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408128![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408103![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408239![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408214![]() (N-(5-(4-(1-(benzo[d]thiazol-5-yl)ethyl)piperazin-1...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408166![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408141![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408110![]() (1-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)-4-(5-methylp...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408108![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408138![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408032![]() (2-(1-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperidin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408222![]() (N-(2-(4-(1-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408117![]() (1-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)-4-(6-methylp...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408105![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408116![]() (1-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)-4-(6-chlorop...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408115![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408109![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408100![]() (5-(1-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperidin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408241![]() (6-(1-(4-(5-(trifluoromethyl)pyridin-2-yl)piperazin...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408113![]() (Ethyl 2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipe...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408213![]() (N-(5-(4-(1-(benzo[d]thiazol-5-yl)ethyl)piperazin-1...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408129![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408232![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408101![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408106![]() (1-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)-4-(pyridin-2...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408145![]() (2-(4-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)ethyl...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408186![]() (Ethyl-2-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-y...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408196![]() (N-(5-(4-(1-(4-chloroquinolin-7-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408190![]() (6-(1-(4-(4-(trifluoromethyl)pyrimidin-2-yl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408197![]() (N-(2-(4-(1-(4-chloroquinolin-7-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408236![]() (2-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-yl)thia...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408254![]() (2-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-yl)-6,7...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408123![]() (Ethyl 2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipe...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408220![]() (N-(5-(4-(1-(benzo[c][1,2,5]thiadiazol-5-yl)ethyl)p...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408184![]() (N-(5-(4-(1-(4-chloro-3-methoxyphenyl)ethyl)piperaz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408155![]() ((R)-2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408102![]() (2-(4-(1-(Benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408173![]() (US10336775, Example 77 | US10336775, Example 78) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408159![]() ((R)-2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)e...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408255![]() (N-(5-(4-(1-(benzo[d]thiazol-6-yl)ethyl)piperazin-1...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408234![]() ((S)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408231![]() (2-(4-(1-(quinoxalin-6-yl)ethyl)piperazin-1-yl)benz...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408223![]() (N-(2-(4-(1-(quinolin-8-yl)ethyl)piperazin-1-yl)pyr...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408217![]() (N-(2-(4-(1-(benzo[c][1,2,5]oxadiazol-5-yl)ethyl)pi...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408170![]() ((R)-(2-(4-(1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408161![]() ((R)-2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pipera...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408277![]() (3-Methyl-7-(1-(4-(pyrimidin-2-yl)piperazin-1-yl)et...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408221![]() (N-(2-(4-(1-(3-chloroquinolin-7-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408099![]() (1-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)-4-(4-methyl-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408227![]() (N-(2-(4-(1-(quinolin-3-yl)ethyl)piperazin-1-yl)pyr...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408183![]() (N-(2-(4-(1-(3,4-Dichlorophenyl)ethyl)piperazin-1-y...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408112![]() (2-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)piperazin-...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408250![]() (US10336775, Example 174) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408164![]() ((R)-N-(5-(4-(1-(benzo[d][1,3]dioxol-5-yl)ethyl)pip...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM408172![]() (N-(5-(4-(1-(3,4-difluorophenyl)ethyl)piperazin-1-y...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Asceneuron SA US Patent | Assay Description 5 μl of the appropriate concentration of a solution of inhibitor in McIlvaine's Buffer (pH 6.5) in 2% DMSO (for a dose response curve calcul... | US Patent US10336775 (2019) BindingDB Entry DOI: 10.7270/Q27083SC | |||||||||||
More data for this Ligand-Target Pair |